Zacks Research Issues Negative Forecast for MRK Earnings
Research analysts at Zacks Research lowered their Q4 2026 EPS estimates for shares of Merck & Co., Inc. in a report released ...
Zacks Research Analysts Decrease Earnings Estimates for MRK
Research analysts at Zacks Research reduced their Q1 2026 EPS estimates for shares of Merck & Co., Inc. in a research note issued to investors on Tuesday, April 1st. Zacks Research analyst S. Ganoria ...
Potatoes, discount chains and drugmakers offer havens in stock-market bloodbath
Potato producer Lamb Weston Holdings Inc., telecom giant Verizon Communications Inc. and retailer TJX Cos. all bucked a sharp market selloff Thursday, as Wall Street turned to stocks offering exposure ...
Stay defensive during upheaval in stocks ignited by Trump tariff plan, Bahnsen says
Consumer Staples sector (NYSEARCA:XLP) was the lone gainer in Thursday’s stock rout, a move in line with a suggestion from ...
Zacks Investment Research on MSN12h
Merck (MRK) Stock Moves -0.24%: What You Should Know
Merck (MRK) closed the most recent trading day at $86.39, moving -0.24% from the previous trading session. The stock exceeded the S&P 500, which registered a loss of 4.84% for the day. Meanwhile, the ...
TD Cowen Keeps Their Hold Rating on Merck & Company (MRK)
TD Cowen analyst Steve Scala maintained a Hold rating on Merck & Company (MRK – Research Report) today and set a price target of $100.00.
Explore more